US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

TriMix Injection

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0115-2023
Class II · Moderate risk Terminated

TriMix Injection

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0114-2023
Class II · Moderate risk Terminated

TriMix Injection

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0113-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0112-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0111-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0110-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0109-2023
Class II · Moderate risk Terminated

QuadMix Super 002

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0108-2023
Class II · Moderate risk Terminated

QuadMix Standard 001

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0107-2023
Class II · Moderate risk Terminated

TriMix Original

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0106-2023
Class II · Moderate risk Terminated

QuadMix Super 001

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0105-2023
Class II · Moderate risk Terminated

QuadMix Standard 002

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0104-2023
Class II · Moderate risk Terminated

QuadMix Plus

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0103-2023
Class II · Moderate risk Terminated

Mitomycin Injection Solution

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0102-2023
Class II · Moderate risk Completed

Heparin Sodium 2

Reason Lack of assurance of sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-7620-59 D-0097-2023
Class II · Moderate risk Terminated

Rasagiline Mesylate Tablets 1 mg

Reason Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

Ascend Laboratories, LLC NDC 67877-260-30 D-0159-2023
Class II · Moderate risk Ongoing

Acyclovir Sodium Injection 1

Reason Presence of Particulate Matter: Customer complaint of dark particles found inside the vial

Eugia US LLC NDC 55150-155-20 D-0095-2023
Class II · Moderate risk Terminated

BuPROPion Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications

Amerisource Health Services LLC D-0328-2023
Class II · Moderate risk Terminated

Vitamin K

Reason Lack of sterility assurance

Sentara Infusion Services D-0324-2023
Class II · Moderate risk Terminated

Vancomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0323-2023
Class II · Moderate risk Terminated

Vancomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0322-2023
Class II · Moderate risk Terminated

TPN 107gm/AA

Reason Lack of sterility assurance

Sentara Infusion Services D-0319-2023